Clinical Trial Update: Study of Novel Treatment Combinations in Patients With Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial sponsored by Gilead Sciences is evaluating novel treatment combinations in patients with non-small cell lung cancer and is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Gilead Sciences | Conditions: Lung Cancer, Advanced or Metastatic Non-Small-Cell Lung Cancer | Phase 2 | Status: RECRUITING